Info
01480 839 015

  • awesomeicons6/solid/lock 100% Secure Online Payments

Alacizumab (Anti-VEGFR2 / KDR / CD309)

Alacizumab (Anti-VEGFR2 / KDR / CD309) (A3109-GRP)

Alacizumab (Anti-VEGFR2 / KDR / CD309) is a humanized monoclonal antibody targeting VEGFR2 / KDR / CD309 . It has anti-tumour effect in tumour growth. MW :144.08 KD.
View Data Sheet
Products
Sort by arrow-down-short-wide arrow-up-short-wide
Cat #
Size
Price
Cat # Size
chevron-left chevron-right
of
Description
Alacizumab (Anti-VEGFR2 / KDR / CD309) is a humanized monoclonal antibody targeting VEGFR2 / KDR / CD309 . It has anti-tumour effect in tumour growth. MW :144.08 KD.
Specifications
Manufacturer Cat# A3109
Related Documents